Background Biliary stricture is a common cause of morbidity after liver transplantation. We previously developed a duct-toduct biliary anastomosis technique using a biodegradable stent tube and confirmed the feasibility and safety of biliary stent use. However, the duration and mechanism of biliary stent absorption in the common bile duct remain unclear. Materials and methods Radiopaque biodegradable biliary stents were created using a copolymer of L-lactide and ε-caprolactone (70: 30) and coated with barium sulfate. Stents were surgically implanted in the common bile duct of 11 pigs. Liver function tests and computed tomography (CT) scans were performed postoperatively, and autopsies were conducted 6 months after biliary stent implantation. Results After the surgery, all 11 pigs had normal liver function and survived without any significant complications such as biliary leakage. A CT scan at 2 months post-procedure showed that the biliary stents were located in the hilum of the liver. The stents were not visible by CT scan at the 6-month followup examination. Conclusions The surgical implantation of radiopaque biodegradable biliary stents in biliary surgery represents a new option for duct-to-duct biliary reconstruction. This technique appears to be feasible and safe and is not associated with any significant biliary complications. The advantage of coated biliary stent use is that it may be visualized using abdominal radiography such as CT.
Introduction
Refinements in surgical techniques and postoperative management have reduced the incidence of biliary complications such as stricture after living donor liver transplantation (LDLT) with duct-to-duct biliary reconstruction [1] . Studies performed after 2007 have indicated a promising and marked decrease in the overall incidence of biliary stricture in LDLT recipients (17-25.3 % before 2008 vs. 7.2-10.2 % after 2008) [2] [3] [4] [5] . Minimal dissection of the hilar duct and the complete Glissonian technique maintains a maximal blood supply to the bile duct in both donor and recipient surgery and has contributed to this reduction in the incidence of biliary stricture after duct-to-duct biliary reconstruction in LDLT. However, biliary strictures continue to be a significant cause of morbidity after liver transplantation and are associated with lengthier hospital stays, increased costs, decreased quality of life, and repeated therapeutic interventions.
An ideal method for preventing biliary stricture after LDLT with duct-to-duct biliary reconstruction may involve the surgical placement of a biodegradable biliary stent at the duct-toduct biliary anastomosis site. Unlike plastic stents, biodegradable biliary stents do not require subsequent removal. Indeed, if the stent remains patent for a long period, it may prevent the occurrence of biliary stricture after liver transplantation.
We previously developed a biodegradable biliary stent for internal use in duct-to-duct biliary reconstruction in pigs. This stent was shown to have good patency and was absorbed by postoperative day 180 [6] . While we did confirm that this stent could be safely and effectively used as an internal biliary stent, the actual duration of absorption remained unclear as the stent could not be observed using radiography.
We therefore developed a radiopaque biodegradable biliary stent, which is coated with barium sulfate and can be detected using radiography. In the present study, we evaluated this stent's patency as well as the rate of absorption and any detrimental side effects.
Materials and methods

Material synthesis
The radiopaque biodegradable synthetic stent tube was manufactured experimentally by the JMS company (JMS Co. LTD., Hiroshima, Japan), as previously described. The biodegradable material was synthesized by copolymerization of L-lactide and ε-caprolactone (70:30) [6] and coated with barium sulfate (Fig. 1 ).
For the in vitro degradation studies, samples (n = 3) of the copolymer of L-lactide and ε-caprolactone [P(LA/CL)] were molded into a sheeted dumb-bell shape of 300 μm thickness and sterilized using ethylene oxide gas. The sheeted P(LA/ CL) samples were immersed in containers that were sterilized using ethylene oxide gas and contained either a 50-ml phosphate buffered saline (PBS) or bile juice (containing 0.1 % NaN3) solution. The PBS and bile juice solutions were replaced on a weekly basis, and containers were stored at 37°C for 6 weeks. The molecular weight (Mw) of the samples during hydrolytic degradation was determined using gel permeation chromatography (GPC), performed with an HPLC system comprised of 600 pumps, a 717 Plus Autosampler, and a 2410 refractive index detector (Waters, USA). The ratio of LA and CL of samples was determined using proton nuclear magnetic resonance (1H-NMR). In terms of mechanical properties, tensile tests were performed using a tensile testing machine AG-IS 5kN (Shimadzu Corp., Kyoto, Japan) at a speed of 50 mm/min.
A total of 11 pigs weighing approximately 20 kg each were implanted with the biliary stents. Animals were housed under standard conditions with a 12-h light/dark cycle and fed a typical diet. Animals were handled in accordance with the Animal Regulations of Hiroshima University. Animals were pre-medicated with an intramuscular injection of ketoral. Once intubated, they were anesthetized with propofol and ventilated using a respirator. A median upper abdominal laparotomy was performed, after which the peritoneal cavity was assessed, and a liver biopsy performed to ensure that no macroscopically discernible or histopathologically detectable hepatobiliary organ pathologies were present prior to the surgical procedure. A segment of the common bile duct (CBD) approximately 2 cm in length was evaluated and transected below the entrance of the cystic duct. An internal stent with a diameter of 4-5 mm and a length of approximately 10 mm was inserted into the CBD and secured with 6-0 polydioxanone absorbable monofilament sutures. Sutures were placed with interrupted 6-0 polydioxanone absorbable monofilament stitches in order to anastomose the transected bile duct.
To evaluate the patency of the inserted absorbable stent tube in the CBD, blood samples were collected from the jugular vein to determine total bilirubin (T-Bil) and alanine aminotransferase (ALT) levels at postoperative months 2 and 6. Computed tomography (CT) scans were performed approximately 2 months post-procedure, and drip infusion cholangiography was performed simultaneously. A laparotomy was performed, and the CBD and liver were excised for histological examinations 6 months post-procedure. Results of the liver function tests were compared using a paired Student's t test, and a P value < 0.05 was considered statistically significant. Statistical analysis was performed using the SPSS software package (SPSS, Ver. 16, Japan Inc., Tokyo, Japan). 
Results
(1.) In vitro study: P(LA/CL) samples began to degrade immediately on immersion in the PBS and bile juice solutions. Samples immersed in bile juice degraded at a faster rate than those immersed in the PBS solution (Fig. 2a) . The tensile strength also gradually decreased as samples were immersed in the bile juice solution (Fig. 2b) .
(2.) Implantation study: At the follow-up examination, no postoperative complications were observed in any of the animals. The CT scan performed approximately 2 months postoperatively indicated that the biliary stent was located in the hilum of the liver (Fig. 3) . In a single pig that underwent biliary stent implantation, drip infusion cholangiography in combination with CT was performed 2 months post-procedure in order to observe the position of the biliary stent. The CT scan showed that the biliary stent was located in the CBD without migration (Fig. 4) . Liver function tests at the follow-up examination showed that serum levels of T-Bil and ALT were almost within normal range (Fig. 5) . Moreover, no significant differences were noted in the serum levels of T-Bil and ALT when measured at both 2 and 6 months post-procedure. The CBDs removed at 6 months post-procedure did not show any residual biliary stents. On histological examination, removed CBDs showed normal tissue architecture with slight inflammatory changes (Fig. 6a and b) . Finally, none of the livers explanted at 6 months post-procedure showed findings of cholestasis (Fig. 6c ).
Discussion
In a previous study, we showed that duct-to-duct biliary reconstruction with an absorbable internal stent that was not coated with radiopaque material had good patency. Moreover, anastomoses were not accompanied by signs of biliary leakage in any of the animals, and no stone formation was observed. This uncoated biliary stent was completely absorbed within 6 months. However, the actual duration of absorption of the non-radiopaque material remains unclear. Precise observation of the displacement and degradation process of the biliary stent is of clinical importance.
In the present study, we examined the in vitro degradation of P(LA/CL) samples. P(LA/CL) samples were shown to degrade more rapidly when immersed in a bile juice solution than when immersed in a PBS solution. The bile acids could promote the degradation of P(LA/CL); however, the mechanism of this increased degradation is unclear. Furthermore, it is possible that in vivo degradation of P(LA/CL) is increased when compared with in vitro degradation, as bile juice is produced and flows into the bile duct at a rate greater than 600 ml/day.
Several studies have reported the efficacy and feasibility of absorbable biliary stents in experimental and preliminary clinical studies. Miyazawa et al. established an extrahepatic bile duct injury repair model using a bioabsorbable polymer patch and confirmed the presence of a neo-bile duct with cuboidal columnar epithelium that stained positive for cytokeratin 19 after absorption of an artificial stent [7, 8] . In a preliminary clinical study, biodegradable biliary stents were implanted percutaneously in 10 patients with recurrent cholangitis due to benign biliary stenosis that was refractory to other treatments [9] . In that study, none of the 10 patients required any further invasive treatment during a median follow-up period of 16.5 months, although 3 patients experienced transient episodes of cholangitis. Few studies have investigated radiopaque biodegradable biliary stents; however, a braided polylactide-barium sulfate biodegradable radiopaque stent was recently developed and applied to a hepaticojejunostomy in mini-pigs using a purse-string anastomosis [10] . The animals underwent repeated radiography procedures and liver biochemistry tests, and the stents were absorbed within 3 months. In addition, no complications such as biliary stenosis or biliary leakage were observed. To the best of our knowledge, the application of radiopaque biodegradable biliary stents in duct-to-duct biliary reconstruction has not been previously discussed. Thus, this is the first study wherein application of these biliary stents was followedup with using CT. In the present study, we showed that a radiopaque biodegradable biliary stent had good patency in all animals that underwent duct-to-duct biliary reconstruction and that this stent was absorbed without any detrimental side effects. Furthermore, the position and shape of the biliary stent were confirmed on a follow-up CT scan post-procedure. However, a limitation of the study is the lack of short-term follow-up examinations using CT; and as such, the degradation process itself could not be observed using CT. Future studies should therefore include follow-up examinations with shorter, 1-month interval. In addition, the results presented in Fig. 2 indicate that the shape of the implanted biliary stent remained Btube-like^when measured 2 months post-procedure. However, the in vitro study showed that the strength of the biliary stent had decreased considerably 6 weeks after immersion in a bile juice solution. It is therefore recommended that a biliary stent with a higher ratio of L-lactide to ε-caprolactone (such as, 80:20) should be used, in order to increase the strength of the biliary stent and lower the rate of degradation.
On histological examination, explanted CBDs showed normal tissue architecture, suggesting that the radiopaque biodegradable stent had no detrimental effects on the bile duct itself. Indeed, not only is barium sulfate routinely used for enema procedures in a clinical setting, but we have previously shown that a biodegradable stent created using copolymerization of L-lactide and ε-caprolactone is safe and feasible [6] . As the biodegradable stent is coated with barium sulfate, we can assume that it is safe to use.
Limitations of our study are as follows: (1) It remains unclear whether this biodegradable biliary stent can prevent the anastomosed bile duct from stricture in a clinical setting. In the future, we plan to evaluate the usefulness and effectiveness of the biodegradable biliary stents for biliary stricture. (2) The biodegradable biliary stent may cause cholangitis due to cholestasis during liver transplantation, although biliary complications such as biliary stones were not observed in this study. In case of intractable cholangitis due to cholestasis, we may need an invasive modality such as endoscopic retrograde cholangiopancreatography (ERCP).
In conclusion, the present study showed that an absorbable, internal stent coated with radiopaque material (barium sulfate) used in duct-to-duct biliary reconstruction yielded good results. The advantages of this radiopaque biliary stent include visualization of the position and shape of the biliary stent by CT or radiography, good patency, and safety, as it is not coated with radiopaque material.
